logo

Acute exposure to high-peak-power pulsed microwaves affecting the histamine H3 receptor expression in rat hippocampus

RADIOCHEMISTRY, RADIOPHARMACEUTICALS AND NUCLEAR MEDICINE

Acute exposure to high-peak-power pulsed microwaves affecting the histamine H3 receptor expression in rat hippocampus

YU Xiao-Dong
LI Bo
LI De-Hua
HE Qi-Yi
YU Zheng-Ping
Nuclear Science and TechniquesVol.17, No.4pp.227-231Published in print 20 Aug 2006
36000

In the Morris Water Maze test, high-peak-power pulsed microwave (MW)-exposed rats displayed some learning and memory behavior dysfunctions, and their escape time and swimming distance to the submerged platform were longer than those of the sham-exposed rats. To understand the molecular mechanism involved, the reverse transcription-polymerase chain reaction (RT-PCR) and the Western-blotting technique were used for investigating the mRNA and protein expression patterns of the histamine H3 receptor (H3R) in rat hippocampus. High-peak-power pulsed microwave-exposure did not remarkably lead to the change in expression of H3R mRNA in rat hippocampi; however, it promoted the up-regulatory expression of the H3R protein, which was possibly triggered through the mitogen-activated protein kinase (MAPK) pathways. Therefore, further investigation of the molecular mechanism of the MW effects on the learning and memory behaviors is required.

Histamine H3-receptorRat hippocampusMicrowaveExpression
References
[1] D’Andrea J A, Chou C K, Johnston S A, et al. Bioelectromagnetics (supp.), 2003, 6: s107-s147.
[2] Vander V A, Duhamel F, IEEE Trans Microw Theory Tech, 1996, 44:1898-1909.
[3] Wang B, Lai H. Bioelectromagnetics, 2000, 21: 52-56.
[4] Alves-Rodrigues A, Timmerman H, Willems E, et al. Brain Research, 1998, 788:179-186.
[5] Bekkers J M, Science, 1993, 261:104-106.
[6] Philippu A, Prast H, Behavioural Brain Research, 2001, 124: 151-159.
[7] Orsetti M, Ghi P, Carlo GD. Behavioural Brain Research, 2001, 124: 235-242.
[8] Toyota H, Dugovic C, Koehl M, et al. Mol Pharmacol, 2002, 62:389-397.
[9] Leurs R, Blandina P, Tedford C, et al. Trends Pharmacol Sci,1998,19:177-183.
[10] Arrange J M, Garbarg M, Schwartz J C. Nature, 1983, 302: 832-837.
[11] Shin N, Coates E, Murgolo N J, et al. Mol Pharmacol, 2002, 62: 38-47.
[12] Hill S J, Ganellin C R, Timmerman H, et al. Pharmacol Rev, 1997, 49:253-278.
[13] Lovenberg T W, Pyati J, Chang H, et al. J Pharmacol Exp Thr, 2000, 293: 771-778.
[14] Drutel G, Peitsaro N, Karlstedt K, et al. Mol Pharmacol,2001, 59:1-8.
[15] Jauchem J R, Frei M R. Aviation, Space and Environmental Medicine, 1995, 66: 992-997.
[16] Cobb B L, Jauchem J R, Adair E R. Bioelectromagnetics, 2004, 25: 49-57.
[17] Blandina P, Giorgetti M, Bartolini L, et al. Br J Pharmacol, 1996, 119: 1656-1664.
[18] Fox G B, Pan J B, Radek R J, et al. JPET, 2003, 305: 897-908.